Parenteral hyperalimentation using lipid is considered an effective and relatively safe method of delivering essential nutrients to patients unable to tolerate enteral feedings. Although the fat overload syndrome is a well-recognized complication of intravenous lipid therapy, its ocular manifestations have not been previously described, to our knowledge.1-3
Report of a Case.
—A 38-year-old Hispanic man was admitted to a community hospital with fever, cough, wheezing, and a lung infiltrate. He was initially treated with bronchodilators, antibiotics, and supplemental oxygen. On the second hospital day parenteral hyperalimentation, which included a 20% fat emulsion infusion (Liposyn II, Abbott Laboratories, Chicago, Ill) was initiated. During the next 5 days the patient was iatrogenically lipid overloaded, receiving 11L of 20% Liposyn II (6.2 g of fat per kilogram of body weight per day). The maximum recommended dosage of Liposyn II is 3.0 g of fat per kilogram of body weight per day. During
Stock JG, Pope J, Enzenauer RW. Retinal Findings in the Fat Overload Syndrome. Arch Ophthalmol. 1990;108(3):329. doi:10.1001/archopht.1990.01070050027012
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: